(Q80407725)

English

Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy

scientific article published on 01 July 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

pancreatic cancer

1 reference

based on heuristic

inferred from title

6

object named as

Prajnan Das

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

James Lewis Abbruzzese

5

object named as

James L Abbruzzese

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Sunil Krishnan

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Vishal Rana

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Nora A Janjan

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Gauri R Varadhachary

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Marc E Delclos

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Morris S Gould

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Douglas B Evans

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Robert A Wolff

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Christopher H Crane

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 July 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

110

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

47-55

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Current management of locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a Phase I trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel and Radiotherapy and Pancreatic Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil and cisplatin.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22735

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22735

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17538975%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80407725&oldid=1818656815"